维普期刊资源整合服务平台（V6.5）

304篇 您的检索式：作者名="SLAMON D"

选中清除导出查看参考文献查看引证文献引用追踪共16页首页上一页第1页下一页末页 /16 跳转

	题名	作者	年代	出处	被引量
1	Role of anthracycline- based therapy in the adjuvant treatment of breast cancer: Efficacy analyses determined by molecular subtypes of the disease 显示文摘	Slamon D J Mackey J Robert N	2007	Breast Cancer Res Treat2007，106，：	1
2	Overall survival advantage to simultaneous chemotherapy plus the humannized anti-HeR2 monoclonal antibody Herceptine in HER2 overexpressing metastatic breast cancer 显示文摘	Norton L Slamon D Leyland-Jones b	1999	Proc Am Soc Clin Oncol1999，18，：	1
3	HER-2/neu signal transduction in human breast and ovarian cancer显示文摘	Reese D M Slamon D J	1997	Stem Cells1997，15，1：	1
4	Human breast cancer correlation of relapse and survival with amplification of the HER-2/nen oncogene显示文摘	Slamon D Clark G Wong S	1987	Science1987，235，4875：	1
5	Use of chemotherapy plus a monoclonal antibody against I-IER2 for meta- static breast cancer that overexpresses HER2 显示文摘	SLAMON D J LEYLAND JONES B SHAK S	2001	N Engl J Med2001，344，11：	1
6	Phase Ⅲ randomized trial comparing doxorubicin and cyclophosphamide followed by docetaxel (AC→T) with doxorubicin and cyclophosphamide followed by docetax- el and trastuzumab (AC→TH) with docetaxel, carboplatin and trastu- zumab(TCH) in HER2 positive early breast cancer patients: BCIRG 006 study显示文摘	Slamon D Eiermann W Robert N	2006	Breast Cancer Res Treat2006，100，1：	1
7	Human breast cancer:correlation of relapse and survival with amplification of the HER-2/neu oncogene显示文摘	SLAMON D J CLARK G M WONG S G	1987	Science1987，235，4785：	1
8	Addition of herceptin (humanized anti-HER2 antibody ) to tirst line chemotherapy for HEP,2 overexpressing metastatic breast cancer ( HER2 +/MBC ) markedly increases anticancer activity: a randomized multinational controlled phase Ⅲ trial 显示文摘	Slamon D Leyland-Jones B Shak S	1998	Proc Am Soc Clin Oncol1998，377，17：	1
9	Expression of a multidrug-resis-tance gene in human tumors and tissues显示文摘	Fojo A T Uede K Slamon D J	1987	Proc Natl Acad Sci USA1987，84，1：	1
10	Adjuvant trastuzumab in HER2-Positive breast cancer显示文摘	Slamon D Eiermann W Robert N	2011	N Engl J Med2011，365，14：	1
11	Addition of Herceptin to first line chemotherapy for Her- 2 overexpressing metastatic breast cancer (Her-2 +/MBC) markedly increases anti cancer activity:a randomized multinational controlled phase Ⅲ trial 显示文摘	Slamon D Leyland-Jones B Shak S	1998	Proceedings ASCO1998，，：	1
12	Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer显示文摘	Slamon D J Godolphin W Jones L A	1989	Science1989，244，4905：	1
13	Combination therapy with trastuzuanrb (Hecreptin) and cispaltin for chemoresist intantmetastatci breast cancer; evidence for receptor-enhanced chemosensitive显示文摘	Pegram M D Slamon D J Dennis J S	1999	Semin Oncol1999，26，：	1
14	Hormonal modulation of HER-2/neu protooncogene messenger ribonucleic acid and p185 protein expression in human breast cancer cell lines 显示文摘	Read LD Keith D Jr Slamon DJ	1990	Cancer Res1990，50，13：	1
15	Biological rationale for HER2/neu(c-erbB2)as a target for monoclonal antibody therapy显示文摘	Pegram M Slamon D	2000	Semin Oncol2000，27，59：	1
16	Adjuvant trastuzumab in HER-2-posidve breast cancer显示文摘	Slamon D Eiermann W Robert N	2011	N Engl J Med2011，365，14：	1
17	Retinoic-acid-resistant neuroblastoma cell lines show altered MYC regulation and high sensitivity to fenretinide 显示文摘	Reynolds CP Wang Y Melton LJ Einhorn PA Slamon D J Maurer BJ	2000	Med Pediatr Oncol2000，35，6：	1
18	Use of chemotherapy plus a monoclanal antibody against HER2 for metastatic breast cancer that overexpresses HER2显示文摘	Slamon D J Leyland-Jones B Shak S	2001	N Engl J Med2001，344，11：	1
19	Human breast canc- er: correlation of relapse and survival with amplification of the HER-2/neu oncogene显示文摘	Slamon D J Clark G M Wong S G	1987	Science1987，235，4785：	1
20	Addition of herceptin ( humanized anti -HER2 antibody) to first line chemotherapy for HER2 overex- pressing metastatic breast cancer markedly increases anti - cancer activity : a randomized, multinational controlled phase III trial 显示文摘	Slamon D Leyland Jones B	1998	Proc Am Soc Clin Oncol1998，17，：	1

返回顶部每页显示：

共16页首页上一页第1页下一页末页 /16 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示